(Q34479133)

2 August 2017

1 reference

title

A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus (English)

1 reference

2 August 2017

0 references

1 reference

Chilcott J

1

1 reference

2 August 2017

Tappenden P

series ordinal

2

1 reference

2 August 2017

Jones ML

series ordinal

3

1 reference

2 August 2017

Wight JP

series ordinal

4

1 reference

2 August 2017

1 November 2001

1 reference

2 August 2017

Clinical Therapeutics

1 reference

2 August 2017

23

1 reference

2 August 2017

1792-823; discussion 1791

1 reference

2 August 2017

11

1 reference

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980078-8

7 January 2021

"Glitazones", a prospect for non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980078-8

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980078-8

7 January 2021

Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980078-8

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980078-8

7 January 2021

Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980078-8

7 January 2021

Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980078-8

7 January 2021

Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980078-8

7 January 2021

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980078-8

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980078-8

7 January 2021

Antidiabetic drugs present and future: will improving insulin resistance benefit cardiovascular risk in type 2 diabetes mellitus?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980078-8

7 January 2021

A comparison in a clinical setting of the efficacy and side effects of three thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980078-8

7 January 2021

10.1016/S0149-2918(00)80078-8

Identifiers

DOI

1 reference

2 August 2017

1 reference